Disparities in SARS-CoV-2 Vaccination-to-Infection Risk During the COVID-19 Pandemic in Massachusetts.
Journal
JAMA health forum
ISSN: 2689-0186
Titre abrégé: JAMA Health Forum
Pays: United States
ID NLM: 101769500
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
13
05
2021
accepted:
23
07
2021
entrez:
17
8
2022
pubmed:
18
8
2022
medline:
18
8
2022
Statut:
epublish
Résumé
This cohort study examines the alignment of vaccination and SARS-CoV-2 risk in Massachusetts by creating and applying a vaccination-to-infection risk ratio.
Identifiants
pubmed: 35977180
doi: 10.1001/jamahealthforum.2021.2666
pii: ald210018
pmc: PMC8796904
doi:
Substances chimiques
Antibodies, Viral
0
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
e212666Subventions
Organisme : NIAID NIH HHS
ID : K08 AI141740
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI131928
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI060354
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069412
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright 2021 Dryden-Peterson S et al. JAMA Health Forum.
Déclaration de conflit d'intérêts
Conflict of Interest Disclosures: Dr Dryden-Peterson reported grants from the National Institutes of Health during the conduct of the study. Dr Velásquez reported grants from the National Institute of Allergy and Infectious Diseases during the conduct of the study and grants from the Unitaid endTB-Q trial outside the submitted work. Dr Gandhi reported personal fees from Merck and Gilead for serving on scientific advisory boards outside the submitted work. No other disclosures were reported.
Références
Ann Epidemiol. 2018 Dec;28(12):841-849
pubmed: 29983236
JAMA Netw Open. 2021 Jan 4;4(1):e2032696
pubmed: 33416882
N Engl J Med. 2021 May 6;384(18):e67
pubmed: 33691058
Sci Adv. 2021 Oct;7(40):eabj2099
pubmed: 34586843